Search research articles
Contact Us
Filters
Showing results (171-180 of 296) with videos related to
Page
of 30
Sort By:
IJTLD Open
|
November 17, 2025
Depression in adolescents on treatment for rifampicin-susceptible TB in Lima, Peru
V Sanchez-Guzman, J R Tanzer, B Roman-Sinche, et al.
IJTLD Open
|
January 19, 2026
Fifteen years of rifampicin-resistant TB control in Niger: high countrywide treatment uptake and success
I Maman Lawan, T Decroo, M B Souleymane, et al.
IJTLD Open
|
October 15, 2025
Factors associated with unfavorable tuberculosis treatment outcomes in the population deprived of liberty
K Z Ely, M L Draschler, T N Prado, et al.
IJTLD Open
|
October 15, 2025
The effect of smart pillboxes on TB stigma among adults in a cluster-randomised TB treatment trial
L Jennings, N Maraba, R Mukora, et al.
IJTLD Open
|
August 18, 2025
Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countries
L Viljoen, H R Draper, N T Castillo-Carandang, et al.
IJTLD Open
|
August 18, 2025
Hepatic safety of pretomanid- and pyrazinamide-containing regimens in TB Alliance clinical trials
J Nedelman, M Li, M Olugbosi, et al.
IJTLD Open
|
August 18, 2025
Community-based pulmonary rehabilitation for post-TB lung disease - a programmatic intervention
B Stenberg, M Drage, B Matewere, et al.
IJTLD Open
|
August 18, 2025
Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB
M B Souleymane, T Decroo, A Soumana, et al.
IJTLD Open
|
July 14, 2025
TB elimination in Southern Africa: overview and critical reflection
J Boffa, D Vambe, C Khosa, et al.
IJTLD Open
|
December 15, 2025
Rapid clinical detection of mycobacterial infections using M-Typer and flow-injection tandem mass spectrometry
A Głogowska, K Majewski, B Szulc, et al.
Page
of 30
Search research articles
Search
Showing results (171-180 of 296) with videos related to
Sort By:
Page
of 30
IJTLD Open
|
November 17, 2025
Depression in adolescents on treatment for rifampicin-susceptible TB in Lima, Peru
V Sanchez-Guzman, J R Tanzer, B Roman-Sinche, et al.
IJTLD Open
|
January 19, 2026
Fifteen years of rifampicin-resistant TB control in Niger: high countrywide treatment uptake and success
I Maman Lawan, T Decroo, M B Souleymane, et al.
IJTLD Open
|
October 15, 2025
Factors associated with unfavorable tuberculosis treatment outcomes in the population deprived of liberty
K Z Ely, M L Draschler, T N Prado, et al.
IJTLD Open
|
October 15, 2025
The effect of smart pillboxes on TB stigma among adults in a cluster-randomised TB treatment trial
L Jennings, N Maraba, R Mukora, et al.
IJTLD Open
|
August 18, 2025
Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countries
L Viljoen, H R Draper, N T Castillo-Carandang, et al.
IJTLD Open
|
August 18, 2025
Hepatic safety of pretomanid- and pyrazinamide-containing regimens in TB Alliance clinical trials
J Nedelman, M Li, M Olugbosi, et al.
IJTLD Open
|
August 18, 2025
Community-based pulmonary rehabilitation for post-TB lung disease - a programmatic intervention
B Stenberg, M Drage, B Matewere, et al.
IJTLD Open
|
August 18, 2025
Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB
M B Souleymane, T Decroo, A Soumana, et al.
IJTLD Open
|
July 14, 2025
TB elimination in Southern Africa: overview and critical reflection
J Boffa, D Vambe, C Khosa, et al.
IJTLD Open
|
December 15, 2025
Rapid clinical detection of mycobacterial infections using M-Typer and flow-injection tandem mass spectrometry
A Głogowska, K Majewski, B Szulc, et al.
Page
of 30